Xi'an Daxing Hospital
Xi’an, Shanxi, 710016, China
NCT Number: NCT05427422
This study is aimed to investigate the post-stroke motor recovery of patients with ischemic stroke based on their neural features extracted from EEG-fMRI data.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Xi’an, Shanxi, 710016, China
A group of patients with ischemic stroke and age/gender matched healthy controls would be enrolled in this study. Their features of neural activities based on EEG-fMRI fusion scan would be extracted to investigate the mechanisms of motor recovery after stroke. Particularly, the correlations of their features of neural networks or local activities to their motor function (defined as their Fugl-Meyer scores) at enrollment and their recovery time courses consisted of Fugl-Meyer scores in follow-up time points. Data of T1 structural, DSI fiber image and pure EEG (without MRI) would also be collected along with EEG-fMRI fusion data.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MRI imaging was performed using a 3 Tesla Siemens Prisma system with a 64-channel head/neck coil (Siemens Medical Systems, Erlangen, Germany). The MRI protocols included as follows: (i) Magnetization-Prepared 2 Rapid Acquisition Gradient Echoes: TR/TE/ TI1/TI2 = 5000/2.98/700/2500 ms, voxel size = 1.0 × 1.0 × 1.0 mm3, FOV = 256 × 240 × 176 mm3; (ii)Gradient-echo EPI: TR 720 ms, TE 33.1 ms, flip angle 52 deg, FOV 208x180 mm, Matrix 104x90, Slice thickness 2.0 mm; 72 slices; 2.0 mm isotropic voxels, Multiband factor 8, Echo spacing 0.58 ms, BW 2290 Hz/Px; (iii) DSI : TR/TE = 3300/73 ms, FOV = 220 × 220 × 60 mm3, voxel size = 2 × 2 × 2 mm3, 128 diffusion direction, b-max = 3000 sec/mm2, AT = 7:22 min); (iv) T2-weighted fluid-attenuated inversion recovery: TR/TE = 9000/84 ms, FOV = 270 × 320 × 22 mm2, voxel size = 0.72 × 0.72 × 6.6 mm3.
EEG was performed using a BrainAmp MR 32 amplifier (BrainProducts GmbH, München, Germany). The EEG protocols included as follows: (i) EEG-fMRI fusion: Sampling rate: 5000 Hz, low cut off-high cut off: DC-1000Hz;(2) EEG-fMRI fusion: Sampling rate: 1000 Hz, low cut off-high cut off: DC-1000Hz.
In (i) an ECG channel would be used to collect artifact of pulse and not used in (ii).
Time frame: 7-14 days since stroke
a scale widely used to evaluate one's motor impairment
Time frame: 6 weeks since stroke
a scale widely used to evaluate one's motor impairment
Time frame: 12 weeks since stroke
a scale widely used to evaluate one's motor impairment
Time frame: 72 weeks since stroke
a scale widely used to evaluate one's motor impairment
Time frame: 7-14 days since stroke
Neuroimage features extracted from EEG-fMRI data
Time frame: 6 weeks since stroke
Neuroimage features extracted from EEG-fMRI data
Time frame: 12 weeks since stroke
Neuroimage features extracted from EEG-fMRI data
Time frame: 72 weeks since stroke
Neuroimage features extracted from EEG-fMRI data
Xi'an Jiaotong University
Other
Motor Recovery of Stroke Patients Based on Electroencephalogram-functional Magnetic Resonance Imaging
Acronym: EEG-fMRI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06478914
Low Intensity Laser, Mononeuropathies
Cairo, Egypt
View Trial DetailsNCT05721040
COVID-19, Coronaviridae Infections
Asyut, Egypt
View Trial DetailsNCT05518136
Cardiopulmonary, Congenital Heart Disease in Children
Beijing, Beijing Municipality, China
View Trial DetailsNCT04054076
Cardiovascular Diseases, Diabetes
Gothenburg, Region Västragötaland, Sweden
View Trial Details